{"DataElement":{"publicId":"4409071","version":"1","preferredName":"Tumor Molecular Prognostic Marker Name","preferredDefinition":"Term to describe a gene or protein for which the expression or presence of can help predict the course and outcome of a tumor.","longName":"4408761v1.0:4408772v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"4408761","version":"1","preferredName":"Tumor Molecular Prognostic Marker Identification","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to or produced by or consisting of molecules._Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease._The procedure of having an identity established","longName":"4409052v1.0:2322316v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"4409052","version":"1","preferredName":"Neoplasm Molecular Prognostic Marker","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Relating to or produced by or consisting of molecules.:Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease.","longName":"C3262:C25574:C20069","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecular","conceptCode":"C25574","definition":"Relating to or produced by or consisting of molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Marker","conceptCode":"C20069","definition":"Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF466D8B-7D94-C107-E040-BB89AD4314A4","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322316","version":"1","preferredName":"Identified","preferredDefinition":"Identified; having the identity known or established.","longName":"C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-0624-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EB3D-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4408772","version":"1","preferredName":"Prognostic Marker Name","preferredDefinition":"Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease._The words or language units by which a thing is known.","longName":"4408772v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"EML4-ALK Translocation","valueDescription":"EML4/ALK Fusion Gene","ValueMeaning":{"publicId":"4408812","version":"1","preferredName":"EML4/ALK Fusion Gene","longName":"4408812","preferredDefinition":"A fusion gene that results from a chromosomal inversion inv(2)(p21p23) which fuses the 5' portion of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene","conceptCode":"C99724","definition":"A fusion gene that results from a chromosomal inversion inv(2)(p21p23) which fuses the 5' portion of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2CDC-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2CF5-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 4","valueDescription":"EML4/ALK Fusion Gene Variant 4","ValueMeaning":{"publicId":"4408814","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 4","longName":"4408814","preferredDefinition":"A fusion gene (~3.4 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 14 of the EML4 gene and an 11 nucleotide linker sequence with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 4","conceptCode":"C99730","definition":"A fusion gene (~3.4 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 14 of the EML4 gene and an 11 nucleotide linker sequence with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D02-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2D1B-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 2","valueDescription":"EML4/ALK Fusion Gene Variant 2","ValueMeaning":{"publicId":"4408816","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 2","longName":"4408816","preferredDefinition":"A fusion gene (~4.7 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 20 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 2","conceptCode":"C99726","definition":"A fusion gene (~4.7 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 20 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D28-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2D41-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 1","valueDescription":"EML4/ALK Fusion Gene Variant 1","ValueMeaning":{"publicId":"4408818","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 1","longName":"4408818","preferredDefinition":"A fusion gene (~3.9 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 13 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 1","conceptCode":"C99725","definition":"A fusion gene (~3.9 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 13 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D4E-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2D67-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"ER positive","valueDescription":"Estrogen Receptor Positive","ValueMeaning":{"publicId":"4264820","version":"1","preferredName":"Estrogen Receptor Positive","longName":"4264820","preferredDefinition":"Describes cells that have a receptor protein that binds the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow, and may stop growing or die when treated with substances that block the binding and actions of estrogen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Positive","conceptCode":"C15492","definition":"An indication that estrogen receptor alpha expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FD23-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2D7B-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EGFRviii mutation","valueDescription":"EGFRvIII Antibody","ValueMeaning":{"publicId":"4277000","version":"1","preferredName":"EGFRvIII Antibody","longName":"4277000","preferredDefinition":"An antibody directed against the epidermal growth factor receptor class III variant (EGFRvIII).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFRvIII Antibody","conceptCode":"C114794","definition":"An antibody directed against the epidermal growth factor receptor class III variant (EGFRvIII).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A2ED0B-933B-456B-E040-BB89AD436E25","latestVersionIndicator":"Yes","beginDate":"2014-04-22","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-04-22","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2D90-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EGFR T790M mutation","valueDescription":"EGFR NP_005219.2:p.T790M","ValueMeaning":{"publicId":"4408819","version":"1","preferredName":"EGFR NP_005219.2:p.T790M","longName":"4408819","preferredDefinition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.T790M","conceptCode":"C98503","definition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2D9D-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2DB6-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EBV","valueDescription":"Epstein-Barr Virus","ValueMeaning":{"publicId":"2567477","version":"1","preferredName":"Epstein-Barr Virus","longName":"2567477","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4A2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2DCA-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"CD79B","valueDescription":"CD79B Gene","ValueMeaning":{"publicId":"4408821","version":"1","preferredName":"CD79B Gene","longName":"4408821","preferredDefinition":"This gene plays a role in signaling in B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD79B Gene","conceptCode":"C97424","definition":"This gene plays a role in signaling in B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2DD8-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2DF1-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"BRAF mutation","valueDescription":"Mutation Abnormality BRAF Gene","ValueMeaning":{"publicId":"4408822","version":"1","preferredName":"Mutation Abnormality BRAF Gene","longName":"4408822","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"BRAF Gene","conceptCode":"C18363","definition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2DFE-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2E17-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Beta-HCG elevated","valueDescription":"Elevated Choriogonadotropin Subunit Beta","ValueMeaning":{"publicId":"4408823","version":"1","preferredName":"Elevated Choriogonadotropin Subunit Beta","longName":"4408823","preferredDefinition":"Raised or increased above normal levels or limits.: The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or Trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (Scan J Clin Lab Invest Suppl 1993;216:97-104)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Choriogonadotropin Subunit Beta 3","conceptCode":"C17479","definition":"Choriogonadotropin subunit beta 3 (165 aa, ~18 kDa) is encoded by the human CGB3, CGB5, and CGB8 genes. This protein is involved in the regulation of steroid synthesis during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E24-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2E3D-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"BCR-ABL translocation","valueDescription":"BCR/ABL1 Fusion Gene","ValueMeaning":{"publicId":"3935833","version":"1","preferredName":"BCR/ABL1 Fusion Gene","longName":"3935833","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-298C-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2E51-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Androgen receptor expression","valueDescription":"Androgen Receptor Positive","ValueMeaning":{"publicId":"4408825","version":"1","preferredName":"Androgen Receptor Positive","longName":"4408825","preferredDefinition":"Describes cells that have a protein that binds to androgens (male hormones). Cancer cells that are AR+ may need androgens to grow. These cells may stop growing or die when they are treated with substances that block the binding and actions of androgen hormones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Androgen Receptor Positive","conceptCode":"C94297","definition":"An indication that expression of androgen receptor has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E5F-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2E78-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"AFP elevated","valueDescription":"Elevated Alpha-Fetoprotein","ValueMeaning":{"publicId":"4408826","version":"1","preferredName":"Elevated Alpha-Fetoprotein","longName":"4408826","preferredDefinition":"Raised or increased above normal levels or limits.: Alpha-fetoprotein is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. (from LocusLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alpha-Fetoprotein","conceptCode":"C16278","definition":"Alpha-fetoprotein (609 aa, ~69 kDa) is encoded by the human AFP gene. This protein plays a role in the binding to copper, nickel, bilirubin and fatty acids in the fetal circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF45AD4A-2E85-CD11-E040-BB89AD435440","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF45AD4A-2E9E-CD11-E040-BB89AD435440","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"RAS mutation","valueDescription":"RAS mutation","ValueMeaning":{"publicId":"4411357","version":"1","preferredName":"RAS mutation","longName":"4411357v1.00","preferredDefinition":"A change in the nucleotide sequence in a RAS family gene (HRAS, KRAS or NRAS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RAS Family Gene Mutation","conceptCode":"C132229","definition":"A change in the nucleotide sequence in a RAS family gene (HRAS, KRAS or NRAS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF474FB1-5FA4-F871-E040-BB89AD43031C","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF474FB1-5FBD-F871-E040-BB89AD43031C","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF474FB1-600D-F871-E040-BB89AD43031C","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"MSH6 mutation","valueDescription":"MSH6 Gene Mutation","ValueMeaning":{"publicId":"4535582","version":"1","preferredName":"MSH6 Gene Mutation","longName":"4535582","preferredDefinition":"A change in the nucleotide sequence of the MSH6 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MSH6 Gene Mutation","conceptCode":"C118395","definition":"A change in the nucleotide sequence of the MSH6 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C990-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05666261-C9A9-BEBD-E050-BB89AD431681","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"MLH1 mutation","valueDescription":"MLH1 Gene Mutation","ValueMeaning":{"publicId":"4535581","version":"1","preferredName":"MLH1 Gene Mutation","longName":"4535581","preferredDefinition":"A change in the nucleotide sequence of the MLH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MLH1 Gene Mutation","conceptCode":"C118394","definition":"A change in the nucleotide sequence of the MLH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C96B-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05666261-C984-BEBD-E050-BB89AD431681","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"CD19","valueDescription":"CD19 gene","ValueMeaning":{"publicId":"3261255","version":"1","preferredName":"CD19 gene","longName":"3261255","preferredDefinition":"This gene plays a role in signal transduction and regulates the response of B cells to antigens.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD19 Gene","conceptCode":"C38886","definition":"This gene plays a role in signal transduction and regulates the response of B cells to antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6634-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-08-10","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF55FCC6-A6D0-17F8-E040-BB89AD432ABD","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-29","modifiedBy":"ONEDATA","dateModified":"2014-07-29","deletedIndicator":"No"},{"value":"CD20","valueDescription":"B-Lymphocyte Antigen CD20","ValueMeaning":{"publicId":"3991503","version":"1","preferredName":"B-Lymphocyte Antigen CD20","longName":"3991503","preferredDefinition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B-Lymphocyte Antigen CD20","conceptCode":"C38896","definition":"B-lymphocyte antigen CD20 (297 aa, ~33 kDa) is encoded by the human MS4A1 gene. This protein plays a role in both the activation and proliferation of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED596A54-CDD6-6922-E040-BB89AD437737","latestVersionIndicator":"Yes","beginDate":"2013-12-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF55FCC6-A6DB-17F8-E040-BB89AD432ABD","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-29","modifiedBy":"ONEDATA","dateModified":"2014-07-29","deletedIndicator":"No"},{"value":"CD5","valueDescription":"CD5 Gene","ValueMeaning":{"publicId":"3991506","version":"1","preferredName":"CD5 Gene","longName":"3991506","preferredDefinition":"This gene may be involved in the proliferation of T-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD5 Gene","conceptCode":"C73121","definition":"This gene may be involved in the proliferation of T-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED596A54-CE09-6922-E040-BB89AD437737","latestVersionIndicator":"Yes","beginDate":"2013-12-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF55FCC6-A705-17F8-E040-BB89AD432ABD","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-29","modifiedBy":"ONEDATA","dateModified":"2014-07-29","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Androgen elevated","valueDescription":"Adrenal Androgen Excess","ValueMeaning":{"publicId":"4408776","version":"1","preferredName":"Adrenal Androgen Excess","longName":"4408776","preferredDefinition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EBC6-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-EBDF-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Cortisol elevated","valueDescription":"Elevated Cortisol","ValueMeaning":{"publicId":"4408774","version":"1","preferredName":"Elevated Cortisol","longName":"4408774","preferredDefinition":"Raised or increased above normal levels or limits.: A hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps the body use glucose (a sugar), protein, and fats. Cortisol made in the laboratory is called hydrocortisone. It is used to treat many conditions, including inflammation, allergies, and some cancers. Cortisol is a type of glucocorticoid hormone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cortisol","conceptCode":"C2290","definition":"A hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps the body use glucose (a sugar), protein, and fats. Cortisol made in the laboratory is called hydrocortisone. It is used to treat many conditions, including inflammation, allergies, and some cancers. Cortisol is a type of glucocorticoid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EBA0-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-EBB9-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EGFR L861Q mutation","valueDescription":"EGFR NP_005219.2:p.L861Q","ValueMeaning":{"publicId":"3799870","version":"1","preferredName":"EGFR NP_005219.2:p.L861Q","longName":"3799870","preferredDefinition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L861Q","conceptCode":"C98497","definition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0285152-B138-3145-E040-BB89AD436AA6","latestVersionIndicator":"Yes","beginDate":"2013-06-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-06-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-EC19-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EGFR L858R mutation","valueDescription":"EGFR NP_005219.2:p.L858R","ValueMeaning":{"publicId":"4408779","version":"1","preferredName":"EGFR NP_005219.2:p.L858R","longName":"4408779","preferredDefinition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L858R","conceptCode":"C98515","definition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EC26-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-EC3F-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EGFR G719X mutation","valueDescription":"EGFR NP_005219.2:p.G719X","ValueMeaning":{"publicId":"3800322","version":"1","preferredName":"EGFR NP_005219.2:p.G719X","longName":"3800322","preferredDefinition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G719X","conceptCode":"C107154","definition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0391E43-574B-5A36-E040-BB89AD433003","latestVersionIndicator":"Yes","beginDate":"2013-06-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-06-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-EC53-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"CD22","valueDescription":"CD22 Gene","ValueMeaning":{"publicId":"3649406","version":"1","preferredName":"CD22 Gene","longName":"3649406","preferredDefinition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD22 Gene","conceptCode":"C20990","definition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B64039-CBBB-975D-E040-BB89AD437C62","latestVersionIndicator":"Yes","beginDate":"2013-01-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-ECA3-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"BRCA2 Mutation","valueDescription":"BRCA2 Gene Mutation","ValueMeaning":{"publicId":"4408782","version":"1","preferredName":"BRCA2 Gene Mutation","longName":"4408782","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA2 Gene Mutation","conceptCode":"C19636","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ECAE-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-ECC7-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"BRCA1 Mutation","valueDescription":"BRCA1 Gene Mutation","ValueMeaning":{"publicId":"4408785","version":"1","preferredName":"BRCA1 Gene Mutation","longName":"4408785","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA1 Gene Mutation","conceptCode":"C19635","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA1 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA1 gene. Approximately 75% of these alterations result in a truncated form of the breast cancer type 1 susceptibility protein. Mutations in the BRCA1 gene predispose individuals to breast and ovarian cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ECF7-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-ED10-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Mineralocorticoids elevated","valueDescription":"Elevated Mineralocorticoid","ValueMeaning":{"publicId":"4408788","version":"1","preferredName":"Elevated Mineralocorticoid","longName":"4408788","preferredDefinition":"Raised or increased above normal levels or limits.: A class of corticosteroid hormones that maintains fluid and electrolyte balance. The main mineralocorticoid is Aldosterone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mineralocorticoid","conceptCode":"C2324","definition":"A class of corticosteroid hormones that maintains fluid and electrolyte balance. The main mineralocorticoid is Aldosterone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ED43-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF444164-ED5C-3A78-E040-BB89AD433300","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G13D mutation","valueDescription":"KRAS NP_004976.2:p.G13D","ValueMeaning":{"publicId":"3528648","version":"1","preferredName":"KRAS NP_004976.2:p.G13D","longName":"3528648","preferredDefinition":"A change in the amino acid residue at position 13 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G13D","conceptCode":"C98403","definition":"A change in the amino acid residue at position 13 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F546-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2019-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6C87-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12D mutation","valueDescription":"KRAS NP_004976.2:p.G12D","ValueMeaning":{"publicId":"3528660","version":"1","preferredName":"KRAS NP_004976.2:p.G12D","longName":"3528660","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12D","conceptCode":"C98369","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F62A-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6C9C-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12C mutation","valueDescription":"KRAS NP_004976.2:p.G12C","ValueMeaning":{"publicId":"3528650","version":"1","preferredName":"KRAS NP_004976.2:p.G12C","longName":"3528650","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by cysteine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12C","conceptCode":"C98365","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by cysteine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F56C-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6CB1-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12A mutation","valueDescription":"KRAS NP_004976.2:p.G12A","ValueMeaning":{"publicId":"3528658","version":"1","preferredName":"KRAS NP_004976.2:p.G12A","longName":"3528658","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by alanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12A","conceptCode":"C98363","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by alanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F604-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2021-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6CC6-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12V mutation","valueDescription":"KRAS NP_004976.2:p.G12V","ValueMeaning":{"publicId":"3528656","version":"1","preferredName":"KRAS NP_004976.2:p.G12V","longName":"3528656","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by valine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12V","conceptCode":"C98391","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by valine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F5DE-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"COLBERTM","dateModified":"2018-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6CDB-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12S mutation","valueDescription":"KRAS NP_004976.2:p.G12S","ValueMeaning":{"publicId":"3528654","version":"1","preferredName":"KRAS NP_004976.2:p.G12S","longName":"3528654","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12S","conceptCode":"C98389","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F5B8-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6CF0-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"KRAS G12R mutation","valueDescription":"KRAS NP_004976.2:p.G12R","ValueMeaning":{"publicId":"3528652","version":"1","preferredName":"KRAS NP_004976.2:p.G12R","longName":"3528652","preferredDefinition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS NP_004976.2:p.G12R","conceptCode":"C98386","definition":"A change in the amino acid residue at position 12 in the GTPase KRas protein where glycine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C50AC764-F592-1CCF-E040-BB89AD436FA2","latestVersionIndicator":"Yes","beginDate":"2012-07-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6D05-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 3","valueDescription":"EML4/ALK Fusion Gene Variant 3b EML4/ALK Fusion Gene Variant 3a","ValueMeaning":{"publicId":"4514732","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 3b EML4/ALK Fusion Gene Variant 3a","longName":"4514732","preferredDefinition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6b of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.: A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6a of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 3b","conceptCode":"C99729","definition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6b of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EML4/ALK Fusion Gene Variant 3a","conceptCode":"C99727","definition":"A fusion gene (~2.5 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 6a of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer. Multiple transcript variants are possible based on the breakpoint for the EML4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B51-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7B6A-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"PIK3CA mutation","valueDescription":"PIK3CA Mutation","ValueMeaning":{"publicId":"4411273","version":"1","preferredName":"PIK3CA Mutation","longName":"4411273","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the PI3KCA (phosphatidyl inositol 3-kinase) gene on chromosome 3q26.32.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3CA Gene Mutation","conceptCode":"C96271","definition":"A change in the nucleotide sequence of the PIK3CA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D3A-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6D53-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"PSA elevated","valueDescription":"Elevated Prostate-Specific Antigen","ValueMeaning":{"publicId":"4411274","version":"1","preferredName":"Elevated Prostate-Specific Antigen","longName":"4411274","preferredDefinition":"Raised or increased above normal levels or limits.: Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D5D-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6D76-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"RET/PTC Rearrangement","valueDescription":"RET/PTC Rearrangement","ValueMeaning":{"publicId":"3743366","version":"1","preferredName":"RET/PTC Rearrangement","longName":"3743366","preferredDefinition":"A gene rearrangement involving the RET proto-oncogene. RET gene rearrangements are associated with several different neoplastic conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RET/PTC Rearrangement","conceptCode":"C46005","definition":"A gene rearrangement involving the RET proto-oncogene. RET gene rearrangements are associated with several different neoplastic conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD277B9-2F3B-7164-E040-BB89AD4339A8","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6D8A-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"SS18-SSX Fusion","valueDescription":"SS18-SSX Fusion Protein Expression","ValueMeaning":{"publicId":"4411275","version":"1","preferredName":"SS18-SSX Fusion Protein Expression","longName":"4411275","preferredDefinition":"The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18-SSX Fusion Protein Expression","conceptCode":"C43306","definition":"The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D97-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6DB0-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"SS18-SSX Fusion - SS18-SSX2","valueDescription":"SS18/SSX2 Fusion Protein","ValueMeaning":{"publicId":"4411276","version":"1","preferredName":"SS18/SSX2 Fusion Protein","longName":"4411276","preferredDefinition":"A fusion protein (488, ~54 kDa) encoded by the SS18/SSX2 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX2, including the SSX transcription repression domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18/SSX2 Fusion Protein","conceptCode":"C99396","definition":"A fusion protein (488, ~54 kDa) encoded by the SS18/SSX2 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX2, including the SSX transcription repression domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6DBC-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6DD5-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"SS18-SSX Fusion - SS18-SSX1","valueDescription":"SS18/SSX1 Fusion Protein","ValueMeaning":{"publicId":"4411277","version":"1","preferredName":"SS18/SSX1 Fusion Protein","longName":"4411277","preferredDefinition":"A fusion protein (488 aa, ~54 kDa) encoded by the SS18/SSX1 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX1, including the SSX transcription repression domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18/SSX1 Fusion Protein","conceptCode":"C99394","definition":"A fusion protein (488 aa, ~54 kDa) encoded by the SS18/SSX1 fusion gene. This protein is comprised of all but the last 8 amino acids of the C-terminus of protein SSXT, fused to the last 78 C-terminal amino acids of protein SSX1, including the SSX transcription repression domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6DE1-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6DFA-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Trisomy 8","valueDescription":"Trisomy 8","ValueMeaning":{"publicId":"2762293","version":"1","preferredName":"Trisomy 8","longName":"2762293","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 8","conceptCode":"C36396","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-013B-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6E50-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"Zap70 Expression","valueDescription":"Gene Expression ZAP70 Gene","ValueMeaning":{"publicId":"4411283","version":"1","preferredName":"Gene Expression ZAP70 Gene","longName":"4411283","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: This gene is involved in tyrosine phosphorylation and T-cell activation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ZAP70 Gene","conceptCode":"C26535","definition":"This gene is involved in tyrosine phosphorylation and T-cell activation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6E5F-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6E78-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"PR positive","valueDescription":"Progesterone Receptor Positive","ValueMeaning":{"publicId":"4411285","version":"1","preferredName":"Progesterone Receptor Positive","longName":"4411285","preferredDefinition":"Describes cells that have a protein to which the hormone progesterone will bind. Cancer cells that are progesterone receptor positive need progesterone to grow and will usually stop growing when treated with hormones that block progesterone from binding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progesterone Receptor Positive","conceptCode":"C15496","definition":"An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6E85-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF469A4B-6E9E-2C10-E040-BB89AD435709","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","deletedIndicator":"No"},{"value":"EML4-ALK Translocation Variant 5","valueDescription":"EML4/ALK Fusion Gene Variant 5b EML4/ALK Fusion Gene Variant 5a","ValueMeaning":{"publicId":"4514735","version":"1","preferredName":"EML4/ALK Fusion Gene Variant 5b EML4/ALK Fusion Gene Variant 5a","longName":"4514735","preferredDefinition":"A fusion gene (~2.1 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with approximately 115 nucleotides of intron 19 and exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.: A fusion gene (~2.0 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EML4/ALK Fusion Gene Variant 5b","conceptCode":"C99732","definition":"A fusion gene (~2.1 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with approximately 115 nucleotides of intron 19 and exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EML4/ALK Fusion Gene Variant 5a","conceptCode":"C99731","definition":"A fusion gene (~2.0 kb) that results from a chromosomal inversion inv(2)(p21p23) which fuses exon 2 of the EML4 gene with exons 20-29 of the ALK gene. This fusion is associated with non-small cell lung cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B79-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7B92-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"Germline Genotype Testing - DNA mismatch Repair","valueDescription":"Mismatch Repair","ValueMeaning":{"publicId":"4514736","version":"1","preferredName":"Mismatch Repair","longName":"4514736","preferredDefinition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mismatch Repair","conceptCode":"C20639","definition":"The mismatch repair (MMR) system promotes genomic fidelity by repairing base-base mismatches, insertion-deletion loops and heterologies generated during DNA replication and recombination. This function is critically dependent on the assembly of multimeric complexes involved in mismatch recognition and signal transduction to downstream repair events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B9E-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7BB7-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"HER2 mutation","valueDescription":"ERBB2 Gene Mutation","ValueMeaning":{"publicId":"4514738","version":"1","preferredName":"ERBB2 Gene Mutation","longName":"4514738","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the ERBB2 gene on chromosome 17q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene Mutation","conceptCode":"C96866","definition":"A molecular genetic abnormality indicating the presence of a mutation in the ERBB2 gene on chromosome 17q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7BDA-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7BF3-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"HER2/Centromere 17 Ratio","valueDescription":"Centromere Chromosome 17 Ratio ERBB2 Gene","ValueMeaning":{"publicId":"4514739","version":"1","preferredName":"Centromere Chromosome 17 Ratio ERBB2 Gene","longName":"4514739","preferredDefinition":"The nonstaining primary constriction of a chromosome which is the point of attachment of the spindle fiber; provides the mechanism of chromosome movement during cell division; the centromere divides the chromosome into two arms, and its position is constant for a specific chromosome: near one end (acrocentric), near the center (metacentric), or between (submetacentric).: The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.: Quotient of quantities of the same kind for different components within the same system.: This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Centromere","conceptCode":"C13198","definition":"The nonstaining primary constriction of a chromosome which is the point of attachment of the spindle fiber; provides the mechanism of chromosome movement during cell division; the centromere divides the chromosome into two arms, and its position is constant for a specific chromosome: near one end (acrocentric), near the center (metacentric), or between (submetacentric).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Human Chromosome 17","conceptCode":"C13212","definition":"The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C02-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7C1B-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"HER2/ERBB2 Status by FISH","valueDescription":"Status Fluorescence in Situ Hybridization ERBB2 Gene","ValueMeaning":{"publicId":"4514740","version":"1","preferredName":"Status Fluorescence in Situ Hybridization ERBB2 Gene","longName":"4514740","preferredDefinition":"A condition or state at a particular time.: A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.: This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C29-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7C42-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"HER2/ERBB2 Status by IHC","valueDescription":"Status Immunohistochemistry Staining Method ERBB2 Protein","ValueMeaning":{"publicId":"4514742","version":"1","preferredName":"Status Immunohistochemistry Staining Method ERBB2 Protein","longName":"4514742","preferredDefinition":"A condition or state at a particular time.: Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.: The ERBB2 gene encodes two forms of ERBB2 protein.  One is a transmembrane protein that forms a heterodimer to act as the heregulin/neuregulin receptor. The other is a secreted form that consists only of the extracellular domain. It is capable of disrupting ERBB2 dimers thereby inhibiting growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ERBB2 Gene Product","conceptCode":"C45842","definition":"A protein encoded by the ERBB2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C51-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7C6A-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"HPV positive","valueDescription":"Human Papillomavirus Positive Finding","ValueMeaning":{"publicId":"4514743","version":"1","preferredName":"Human Papillomavirus Positive Finding","longName":"4514743","preferredDefinition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.: An observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C77-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7C90-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"IgVH gene mutation","valueDescription":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","ValueMeaning":{"publicId":"4514744","version":"1","preferredName":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","longName":"4514744","preferredDefinition":"A change in the nucleotide sequence of the variable region of the immunoglobulin heavy chain locus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin Heavy Chain Locus Variable Region Mutation","conceptCode":"C111690","definition":"A change in the nucleotide sequence of the variable region of the immunoglobulin heavy chain locus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7C9C-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7CB5-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 61","valueDescription":"KRAS mutation - Codon 61","ValueMeaning":{"publicId":"4535569","version":"1","preferredName":"KRAS mutation - Codon 61","longName":"4535569","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A number with no fractional part, including the negative and positive numbers as well as zero.::61: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C8FE-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05666261-C917-BEBD-E050-BB89AD431681","beginDate":"2014-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"CD23","valueDescription":"Low Affinity Immunoglobulin Epsilon Fc Receptor","ValueMeaning":{"publicId":"3241852","version":"1","preferredName":"Low Affinity Immunoglobulin Epsilon Fc Receptor","longName":"3241852","preferredDefinition":": Low affinity immunoglobulin epsilon Fc receptor (321 aa, ~36 kDa) is encoded by the human FCER2 gene. This protein is involved in B cell differentiation and IgE production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Affinity Immunoglobulin Epsilon Fc Receptor","conceptCode":"C96902","definition":"Low affinity immunoglobulin epsilon Fc receptor (321 aa, ~36 kDa) is encoded by the human FCER2 gene. This protein is involved in B cell differentiation and IgE production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4977EB6-0693-43B2-E040-BB89AD435E91","latestVersionIndicator":"Yes","beginDate":"2011-05-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-31","modifiedBy":"ONEDATA","dateModified":"2011-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-79E8-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - None elevated","valueDescription":"None Adrenal Androgen Excess","ValueMeaning":{"publicId":"4514714","version":"1","preferredName":"None Adrenal Androgen Excess","longName":"4514714","preferredDefinition":"No person or thing, nobody, not any.: Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-799F-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-79B8-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"MSH2 - expressed by IHC","valueDescription":"Protein Expression Analysis Immunohistochemistry Staining Method DNA Mismatch Repair Protein Msh2","ValueMeaning":{"publicId":"4535601","version":"1","preferredName":"Protein Expression Analysis Immunohistochemistry Staining Method DNA Mismatch Repair Protein Msh2","longName":"4535601","preferredDefinition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.: Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.: DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression Analysis","conceptCode":"C63480","definition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA Mismatch Repair Protein Msh2","conceptCode":"C21466","definition":"DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-328B-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-32A3-BC37-E050-BB89AD430FA7","beginDate":"2014-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 13","valueDescription":"KRAS mutation - Codon 13","ValueMeaning":{"publicId":"4535551","version":"1","preferredName":"KRAS mutation - Codon 13","longName":"4535551","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A natural number greater than 12 and less than 14 and the quantity that it denotes.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Thirteen","conceptCode":"C113427","definition":"A natural number greater than 12 and less than 14 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05666261-C8B9-BEBD-E050-BB89AD431681","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05666261-C8D2-BEBD-E050-BB89AD431681","beginDate":"2014-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Adrenal Hormone Excess - Unknown elevated","valueDescription":"Unknown Adrenal Androgen Excess","ValueMeaning":{"publicId":"4514715","version":"1","preferredName":"Unknown Adrenal Androgen Excess","longName":"4514715","preferredDefinition":"Not known, not observed, not recorded, or refused.: Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adrenal Androgen Excess","conceptCode":"C113209","definition":"Excessive secretion of the androgen hormones dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, from the adrenal gland. Clinical manifestations may include virilization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-79C5-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-79DE-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"CD45","valueDescription":"Receptor-Type Tyrosine-Protein Phosphatase C","ValueMeaning":{"publicId":"4514716","version":"1","preferredName":"Receptor-Type Tyrosine-Protein Phosphatase C","longName":"4514716","preferredDefinition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Receptor-Type Tyrosine-Protein Phosphatase C","conceptCode":"C17282","definition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-79F5-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7A0E-0ACF-E050-BB89AD43658E","beginDate":"2014-07-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"cKIT mutation","valueDescription":"KIT Gene Mutation","ValueMeaning":{"publicId":"4514717","version":"1","preferredName":"KIT Gene Mutation","longName":"4514717","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A18-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7A31-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"NF1 mutation","valueDescription":"NF1 Gene Mutation","ValueMeaning":{"publicId":"4535602","version":"1","preferredName":"NF1 Gene Mutation","longName":"4535602","preferredDefinition":"A change in the nucleotide sequence of the NF1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene Mutation","conceptCode":"C118388","definition":"A change in the nucleotide sequence of the NF1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32B0-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-32C9-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR activating mutation","valueDescription":"EGFR Activating Mutation","ValueMeaning":{"publicId":"4514722","version":"1","preferredName":"EGFR Activating Mutation","longName":"4514722","preferredDefinition":"A somatic mutation of the epidermal growth factor receptor gene which encodes a 170kDa transmembrane protein, a short transmembrane region, and an intracellular domain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating EGFR Gene Mutation","conceptCode":"C92172","definition":"A somatic mutation of the epidermal growth factor receptor gene which encodes a constitutively active 170kDa transmembrane protein, a short transmembrane region, and an intracellular domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A66-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7A7F-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"p53 mutation","valueDescription":"TP53 Gene Mutation","ValueMeaning":{"publicId":"4535603","version":"1","preferredName":"TP53 Gene Mutation","longName":"4535603","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32D5-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-32EE-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR exon 19 deletion","valueDescription":"EGFR Exon 19 Deletion","ValueMeaning":{"publicId":"4514723","version":"1","preferredName":"EGFR Exon 19 Deletion","longName":"4514723","preferredDefinition":"Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.: The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A natural number greater than eighteen and less than twenty and the quantity that it denotes.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deletion Mutation","conceptCode":"C19296","definition":"Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Nineteen","conceptCode":"C105801","definition":"A natural number greater than eighteen and less than twenty and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A8E-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7AA7-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"PMS2 mutation","valueDescription":"PMS2 Gene Mutation","ValueMeaning":{"publicId":"4535604","version":"1","preferredName":"PMS2 Gene Mutation","longName":"4535604","preferredDefinition":"A change in the nucleotide sequence of the PMS2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PMS2 Gene Mutation","conceptCode":"C118397","definition":"A change in the nucleotide sequence of the PMS2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32FA-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-3313-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"TRAP stain","valueDescription":"Tartrate Resistant Acid Phosphatase Staining Method","ValueMeaning":{"publicId":"4535605","version":"1","preferredName":"Tartrate Resistant Acid Phosphatase Staining Method","longName":"4535605","preferredDefinition":"TRAP Staining; TRACP Staining; TRAP Stain\r\n\r\nA staining method used to demonstrate the presence of acid phosphatase and tartrate resistant acid phosphatase (TRAP) in osteoclasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tartrate Resistant Acid Phosphatase Staining Method","conceptCode":"C118401","definition":"A staining method used to demonstrate the presence of acid phosphatase and tartrate resistant acid phosphatase (TRAP) in osteoclasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-331F-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-3338-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Trisomy 10","valueDescription":"Trisomy 10","ValueMeaning":{"publicId":"4535606","version":"1","preferredName":"Trisomy 10","longName":"4535606","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 10","conceptCode":"C81729","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-3342-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-335A-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR exon 20 insertion","valueDescription":"Insertion Mutation Exon Twenty EGFR Gene","ValueMeaning":{"publicId":"4514724","version":"1","preferredName":"Insertion Mutation Exon Twenty EGFR Gene","longName":"4514724","preferredDefinition":"Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA.: The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insertion Mutation","conceptCode":"C19295","definition":"Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twenty","conceptCode":"C105799","definition":"A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7AB6-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7ACF-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"Trisomy 5","valueDescription":"Trisomy 5","ValueMeaning":{"publicId":"4535607","version":"1","preferredName":"Trisomy 5","longName":"4535607","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 5 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 5","conceptCode":"C36433","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 5 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-3365-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-337D-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"TSC1/2 mutation","valueDescription":"TSC1 Gene Mutation TSC2 Gene Mutation","ValueMeaning":{"publicId":"4535608","version":"1","preferredName":"TSC1 Gene Mutation TSC2 Gene Mutation","longName":"4535608","preferredDefinition":"A change in the nucleotide sequence of the TSC1 gene.: A change in the nucleotide sequence of the TSC2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TSC1 Gene Mutation","conceptCode":"C118398","definition":"A change in the nucleotide sequence of the TSC1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TSC2 Gene Mutation","conceptCode":"C118399","definition":"A change in the nucleotide sequence of the TSC2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-338B-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-33A4-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"VHL mutation","valueDescription":"VHL Gene Mutation","ValueMeaning":{"publicId":"4535609","version":"1","preferredName":"VHL Gene Mutation","longName":"4535609","preferredDefinition":"A change in the nucleotide sequence of the VHL gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"VHL Gene Mutation","conceptCode":"C118400","definition":"A change in the nucleotide sequence of the VHL gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-33B0-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05670046-33C9-BC37-E050-BB89AD430FA7","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR other mutations","valueDescription":"EGFR Other Mutation(s)","ValueMeaning":{"publicId":"4514725","version":"1","preferredName":"EGFR Other Mutation(s)","longName":"4514725","preferredDefinition":"change occurring in one gene.: Different than the one(s) previously specified or mentioned.: This gene is involved in the epidermal growth factor signal transduction pathway.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7ADD-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7AF6-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"EGFR resistance mutation","valueDescription":"EGFR-TKI Resistant Mutation","ValueMeaning":{"publicId":"4514729","version":"1","preferredName":"EGFR-TKI Resistant Mutation","longName":"4514729","preferredDefinition":"A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations of the EGFR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR-TKI Resistant Mutation","conceptCode":"C96862","definition":"A molecular genetic abnormality indicating the presence of resistance in the epidermal growth factor receptor-tyrosine kinase inhibitor domain, due to secondary mutations of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7B29-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7B42-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"isochrome 17","valueDescription":"i(17q)","ValueMeaning":{"publicId":"4422301","version":"1","preferredName":"i(17q)","longName":"4422301","preferredDefinition":"A cytogenetic abnormality involving chromosome 17 that results from loss of the short arm and duplication of the long arm. This aberration is associated with a variety of neoplastic diseases, and is indicative of a poor prognosis for individuals with hematologic malignancies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"i(17q)","conceptCode":"C36477","definition":"A cytogenetic abnormality involving chromosome 17 that results from loss of the short arm and duplication of the long arm. This aberration is associated with a variety of neoplastic diseases, and is indicative of a poor prognosis for individuals with hematologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FFCEFDAA-3E11-D5E0-E040-BB89AD432BA1","latestVersionIndicator":"Yes","beginDate":"2014-08-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7CC9-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"KRAS Other - amplification","valueDescription":"KRAS Other - amplification","ValueMeaning":{"publicId":"4514748","version":"1","preferredName":"KRAS Other - amplification","longName":"4514748v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._A molecular genetic abnormality indicating the presence of multiple copies of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Gene Amplification","conceptCode":"C36665","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D08-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7D21-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"MSI high","valueDescription":"High-Frequency Microsatellite Instability","ValueMeaning":{"publicId":"4514754","version":"1","preferredName":"High-Frequency Microsatellite Instability","longName":"4514754","preferredDefinition":"The presence of genomic instability associated with defective DNA mismatch repair in greater than 30% of the microsatellite instability (MSI) biomarkers in a tumor sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High-Frequency Microsatellite Instability","conceptCode":"C36493","definition":"The presence of genomic instability associated with defective DNA mismatch repair in greater than 30% of the microsatellite instability (MSI) biomarkers in a tumor sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D62-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7D7B-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"NF2 mutation","valueDescription":"NF2 Gene Mutation","ValueMeaning":{"publicId":"4514756","version":"1","preferredName":"NF2 Gene Mutation","longName":"4514756v1.00","preferredDefinition":"A molecular genetic abnormality that refers to the mutation of the NF2 gene located at 22q12.2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF2 Gene Mutation","conceptCode":"C45669","definition":"A molecular genetic abnormality that refers to the mutation of the NF2 gene located at 22q12.2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D88-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04DA251B-7DA1-0ACF-E050-BB89AD43658E","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA","dateModified":"2014-10-07","deletedIndicator":"No"},{"value":"Her2 amplification","valueDescription":"ERBB2 Gene Amplification","ValueMeaning":{"publicId":"4521432","version":"1","preferredName":"ERBB2 Gene Amplification","longName":"4521432","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the ERBB2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene Amplification","conceptCode":"C36638","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the ERBB2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-85E6-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04EC2C02-85FF-49AE-E050-BB89AD430159","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"ONEDATA","dateModified":"2014-10-08","deletedIndicator":"No"},{"value":"KRAS mutation - Codon Other","valueDescription":"KRAS mutation - Codon Other","ValueMeaning":{"publicId":"4521436","version":"1","preferredName":"KRAS mutation - Codon Other","longName":"4521436v1.00","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid._Different than the one(s) previously specified or mentioned._A change in the nucleotide sequence of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Gene Mutation","conceptCode":"C41361","definition":"A change in the nucleotide sequence of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8697-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04EC2C02-86B0-49AE-E050-BB89AD430159","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"ONEDATA","dateModified":"2014-10-08","deletedIndicator":"No"},{"value":"MLH1 expressed by IHC","valueDescription":"Protein Expression Analysis Immunohistochemistry Staining Method MLH1 Gene","ValueMeaning":{"publicId":"4514751","version":"1","preferredName":"Protein Expression Analysis Immunohistochemistry Staining Method MLH1 Gene","longName":"4514751v1.00","preferredDefinition":"Any method of protein detection that can be used to quantify the level of a protein in a sample._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._This gene plays a role in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression Analysis","conceptCode":"C63480","definition":"Any method of protein detection that can be used to quantify the level of a protein in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MLH1 Gene","conceptCode":"C18482","definition":"This gene plays a role in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7D33-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04EC2C02-8701-49AE-E050-BB89AD430159","beginDate":"2014-07-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"ONEDATA","dateModified":"2014-10-08","deletedIndicator":"No"},{"value":"t(12;15)","valueDescription":"t(12;15)","ValueMeaning":{"publicId":"3021321","version":"1","preferredName":"t(12;15)","longName":"3021321","preferredDefinition":"The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the fifteenth largest human autosomal chromosome pair. Chromosome 15 spans about 106 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Chromosome 12","conceptCode":"C13207","definition":"The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Chromosome 15","conceptCode":"C13210","definition":"The designation for each member of the fifteenth largest human autosomal chromosome pair. Chromosome 15 spans about 106 million base pairs and represents between 3 and 3.5% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation","conceptCode":"C3420","definition":"A genetic exchange where a piece of one chromosome is transferred to another chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8186F634-9DD0-4B32-E040-BB89AD433381","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B6DFAA-3ECF-38A5-E050-BB89AD432351","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"t(12;22)","valueDescription":"t(12;22)","ValueMeaning":{"publicId":"3021316","version":"1","preferredName":"t(12;22)","longName":"3021316","preferredDefinition":"The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Chromosome 12","conceptCode":"C13207","definition":"The designation for each member of the twelfth largest human autosomal chromosome pair. Chromosome 12 spans about 143 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Chromosome 22","conceptCode":"C13218","definition":"The designation for each member of the smallest human autosomal chromosome pair. Chromosome 22 spans about 49 million base pairs and represents between 1.5 and 2% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation","conceptCode":"C3420","definition":"A genetic exchange where a piece of one chromosome is transferred to another chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8186F634-9D0D-4B32-E040-BB89AD433381","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B6DFAA-3EDA-38A5-E050-BB89AD432351","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"t(6;9)","valueDescription":"t(6;9)","ValueMeaning":{"publicId":"3021328","version":"1","preferredName":"t(6;9)","longName":"3021328","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 6 and 9.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;9)","conceptCode":"C128650","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 6 and 9.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8186F634-9EE2-4B32-E040-BB89AD433381","latestVersionIndicator":"Yes","beginDate":"2010-03-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B6DFAA-3EE5-38A5-E050-BB89AD432351","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"t(11;19)","valueDescription":"t(11;19)","ValueMeaning":{"publicId":"4621672","version":"1","preferredName":"t(11;19)","longName":"4621672","preferredDefinition":"The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.: The designation for each member of the nineteenth largest human autosomal chromosome pair. Chromosome 19 spans more than 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.: A genetic exchange where a piece of one chromosome is transfered to another chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Chromosome 11","conceptCode":"C13206","definition":"The designation for each member of the eleventh largest human autosomal chromosome pair. Chromosome 11 spans about 134.5 million base pairs and represents between 4 and 4.5% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Chromosome 19","conceptCode":"C13214","definition":"The designation for each member of the nineteenth largest human autosomal chromosome pair. Chromosome 19 spans more than 63 million base pairs and represents between 2 and 2.5% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation","conceptCode":"C3420","definition":"A genetic exchange where a piece of one chromosome is transferred to another chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B6DFAA-3EF4-38A5-E050-BB89AD432351","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B6DFAA-3F0D-38A5-E050-BB89AD432351","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"MYB-NFIB Fusion","valueDescription":"MYB Gene NFIB Gene Fusion Protein","ValueMeaning":{"publicId":"4642080","version":"1","preferredName":"MYB Gene NFIB Gene Fusion Protein","longName":"4642080","preferredDefinition":"This gene plays a role in hematopoietic cell proliferation and development.: This gene plays a role in transcriptional regulation and mediates DNA-binding interactions.: A protein in which the coding region of two genes have become in-frame and co-continuous.  Fusion proteins can be formed by chromosomal breakage and/or recombination and also can be experimentally created using recombinant DNA techniques.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYB Gene","conceptCode":"C28569","definition":"This gene plays a role in hematopoietic cell proliferation and development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"NFIB Gene","conceptCode":"C38401","definition":"This gene plays a role in transcriptional regulation and mediates DNA-binding interactions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fusion Protein","conceptCode":"C17561","definition":"A protein in which the coding region of two genes have become in-frame and co-continuous.  Fusion proteins can be formed by chromosomal breakage and/or recombination and also can be experimentally created using recombinant DNA techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A957D3A-365E-B49D-E050-BB89AD433C30","latestVersionIndicator":"Yes","beginDate":"2014-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A957D3A-3677-B49D-E050-BB89AD433C30","beginDate":"2014-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-19","modifiedBy":"ONEDATA","dateModified":"2014-12-19","deletedIndicator":"No"},{"value":"PD-L1/PD-L2 positive","valueDescription":"PD-L1/PD-L2 amplification","ValueMeaning":{"publicId":"4621742","version":"1","preferredName":"PD-L1/PD-L2 amplification","longName":"4621742","preferredDefinition":"Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells.: Programmed cell death 1 ligand 2 (273 aa, ~31 kDa) is encoded by the human PDCD1LG2 gene. This protein is involved in the modulation of both T-cell proliferation and cytokine production.: An increase in the copy number of a particular gene. This type of abnormality can be either inherited or somatic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Programmed Cell Death 1 Ligand 1","conceptCode":"C96024","definition":"Programmed cell death 1 ligand 1 (290 aa, ~33 kDa) is encoded by the human CD274 gene. This protein is involved in the mediation of both the activation and proliferation of T cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Programmed Cell Death 1 Ligand 2","conceptCode":"C45438","definition":"Programmed cell death 1 ligand 2 (273 aa, ~31 kDa) is encoded by the human PDCD1LG2 gene. This protein is involved in the modulation of both T-cell proliferation and cytokine production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Amplification Abnormality","conceptCode":"C45581","definition":"An increase in the copy number of a particular gene. This type of abnormality can be either inherited or somatic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B7A28A-92CC-3771-E050-BB89AD43163B","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A957D3A-368B-B49D-E050-BB89AD433C30","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-19","modifiedBy":"ONEDATA","dateModified":"2014-12-19","deletedIndicator":"No"},{"value":"MLH1 expressed by PCR","valueDescription":"Gene Expression Polymerase Chain Reaction MLH1 Gene","ValueMeaning":{"publicId":"4521439","version":"1","preferredName":"Gene Expression Polymerase Chain Reaction MLH1 Gene","longName":"4521439","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: method for reproducing specific DNA sequences based on elongation of complementary primers by DNA polymerase; primarily used to increase quantities for analytical detection of, e.g., virus genome.: This gene plays a role in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MLH1 Gene","conceptCode":"C18482","definition":"This gene plays a role in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8737-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05571E19-5D7F-58A2-E050-BB89AD435E1F","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-13","modifiedBy":"ONEDATA","dateModified":"2014-10-13","deletedIndicator":"No"},{"value":"MSH2 - expressed by PCR","valueDescription":"Gene Expression Polymerase Chain Reaction DNA Mismatch Repair Protein Msh2","ValueMeaning":{"publicId":"4521438","version":"1","preferredName":"Gene Expression Polymerase Chain Reaction DNA Mismatch Repair Protein Msh2","longName":"4521438","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.: method for reproducing specific DNA sequences based on elongation of complementary primers by DNA polymerase; primarily used to increase quantities for analytical detection of, e.g., virus genome.: DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA Mismatch Repair Protein Msh2","conceptCode":"C21466","definition":"DNA mismatch repair protein Msh2 (934 aa, ~105 kDa) is encoded by the human MSH2 gene. This protein is involved in DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04EC2C02-8710-49AE-E050-BB89AD430159","latestVersionIndicator":"Yes","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05571E19-5D93-58A2-E050-BB89AD435E1F","beginDate":"2014-10-08","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-13","modifiedBy":"ONEDATA","dateModified":"2014-10-13","deletedIndicator":"No"},{"value":"17p deletion","valueDescription":"Loss of Chromosome 17p","ValueMeaning":{"publicId":"4534971","version":"1","preferredName":"Loss of Chromosome 17p","longName":"4534971","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the short arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 17p","conceptCode":"C36499","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05633FB3-FD67-B268-E050-BB89AD431E51","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05633FB3-FD7F-B268-E050-BB89AD431E51","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Co-amplification of HER2 and Chromosome 17","valueDescription":"EGFR Gene Amplification Gain of Chromosome 17","ValueMeaning":{"publicId":"4535011","version":"1","preferredName":"EGFR Gene Amplification Gain of Chromosome 17","longName":"4535011","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.: A cytogenetic abnormality that refers to the allelic gain of all or part of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene Amplification","conceptCode":"C36649","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gain of Chromosome 17","conceptCode":"C36466","definition":"A cytogenetic abnormality that refers to the allelic gain of all or part of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-96BC-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-96D5-81B7-E050-BB89AD4370A5","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR Amplification","valueDescription":"EGFR Gene Amplification","ValueMeaning":{"publicId":"4535012","version":"1","preferredName":"EGFR Gene Amplification","longName":"4535012","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene Amplification","conceptCode":"C36649","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the EGFR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-96DF-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-96F7-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"EGFR overexpression","valueDescription":"EGFR Protein Overexpression","ValueMeaning":{"publicId":"4535013","version":"1","preferredName":"EGFR Protein Overexpression","longName":"4535013","preferredDefinition":"A molecular genetic abnormality indicating the presence of an abnormally high level of EGFR protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Protein Overexpression","conceptCode":"C39716","definition":"A molecular genetic abnormality indicating the presence of an abnormally high level of EGFR protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9702-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-971A-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"FGF amplification","valueDescription":"FGF Gene Amplification","ValueMeaning":{"publicId":"4535014","version":"1","preferredName":"FGF Gene Amplification","longName":"4535014","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGF family gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGF Gene Amplification","conceptCode":"C118376","definition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGF family gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9727-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9740-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"FGFR amplification","valueDescription":"FGFR Gene Amplification","ValueMeaning":{"publicId":"4535015","version":"1","preferredName":"FGFR Gene Amplification","longName":"4535015","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGFR family gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGFR Gene Amplification","conceptCode":"C118378","definition":"A molecular genetic abnormality indicating the presence of multiple copies of an FGFR family gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-974C-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"COLBERTM","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9765-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"FGFR translocation","valueDescription":"FGFR Gene Translocation","ValueMeaning":{"publicId":"4535016","version":"1","preferredName":"FGFR Gene Translocation","longName":"4535016","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of an FGFR family gene to a new chromosomal location.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGFR Gene Translocation","conceptCode":"C118377","definition":"A cytogenetic abnormality that refers to the translocation of an FGFR family gene to a new chromosomal location.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9771-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"COLBERTM","dateModified":"2019-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-978A-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Germline Genotype Testing - FAP mutations","valueDescription":"Germline Genotype Testing FAP Gene Mutation","ValueMeaning":{"publicId":"4535017","version":"1","preferredName":"Germline Genotype Testing FAP Gene Mutation","longName":"4535017","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the FAP gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"FAP Gene Mutation","conceptCode":"C118386","definition":"A change in the nucleotide sequence of the FAP gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9797-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-97B0-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Germline Genotype Testing - MEN1 mutation","valueDescription":"Germline Genotype Testing MEN1 Gene Mutation","ValueMeaning":{"publicId":"4535018","version":"1","preferredName":"Germline Genotype Testing MEN1 Gene Mutation","longName":"4535018","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the MEN1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"MEN1 Gene Mutation","conceptCode":"C118387","definition":"A change in the nucleotide sequence of the MEN1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-97BD-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-97D6-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Germline Genotype Testing - NF1 mutation","valueDescription":"Germline Genotype Testing NF1 Gene Mutation","ValueMeaning":{"publicId":"4535019","version":"1","preferredName":"Germline Genotype Testing NF1 Gene Mutation","longName":"4535019","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the NF1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NF1 Gene Mutation","conceptCode":"C118388","definition":"A change in the nucleotide sequence of the NF1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-97E3-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-97FC-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Germline Genotype Testing - Other","valueDescription":"Germline Genotype Testing Other","ValueMeaning":{"publicId":"4535020","version":"1","preferredName":"Germline Genotype Testing Other","longName":"4535020","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9809-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9822-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"Germline Genotype Testing - p53 mutation","valueDescription":"Germline Genotype Testing TP53 Gene Mutation","ValueMeaning":{"publicId":"4535021","version":"1","preferredName":"Germline Genotype Testing TP53 Gene Mutation","longName":"4535021","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-982F-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9848-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"IDH1 mutation","valueDescription":"IDH1 Gene Mutation","ValueMeaning":{"publicId":"4535022","version":"1","preferredName":"IDH1 Gene Mutation","longName":"4535022","preferredDefinition":"A change in the nucleotide sequence of the IDH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 Gene Mutation","conceptCode":"C118389","definition":"A change in the nucleotide sequence of the IDH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9854-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-986D-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"IDH2 mutation","valueDescription":"IDH2 Mutation","ValueMeaning":{"publicId":"4535023","version":"1","preferredName":"IDH2 Mutation","longName":"4535023","preferredDefinition":"A change in the nucleotide sequence of the IDH2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 Gene Mutation","conceptCode":"C118390","definition":"A change in the nucleotide sequence of the IDH2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9879-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9892-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"KRAS - activating mutations","valueDescription":"KRAS Activating Mutation","ValueMeaning":{"publicId":"4535024","version":"1","preferredName":"KRAS Activating Mutation","longName":"4535024","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-989E-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-98B7-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"KRAS mutation","valueDescription":"KRAS Activating Mutation","ValueMeaning":{"publicId":"4535025","version":"1","preferredName":"KRAS Activating Mutation","longName":"4535025","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-98C1-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-98D9-81B7-E050-BB89AD4370A5","beginDate":"2014-07-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"KRAS mutation (NOS)","valueDescription":"KRAS Activating Mutation Not Otherwise Specified","ValueMeaning":{"publicId":"4535026","version":"1","preferredName":"KRAS Activating Mutation Not Otherwise Specified","longName":"4535026","preferredDefinition":"Not characterized in any other way.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-98E7-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9900-81B7-E050-BB89AD4370A5","beginDate":"2014-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"KRAS mutation - Codon 12","valueDescription":"KRAS mutation - Codon 12","ValueMeaning":{"publicId":"4535051","version":"1","preferredName":"KRAS mutation - Codon 12","longName":"4535051","preferredDefinition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates  downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Codon","conceptCode":"C62019","definition":"A specific sequence of three adjacent bases on a strand of DNA or RNA that provides genetic code information for a particular amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twelve","conceptCode":"C113426","definition":"A natural number greater than 11 and less than 13 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"KRAS Activating Mutation","conceptCode":"C118391","definition":"A change in the nucleotide sequence of the KRAS gene that that results in constitutive signal transduction, which stimulates downstream signaling pathways involved in cell growth, proliferation, invasion, and metastasis. The presence of KRAS activating mutations in colorectal cancer and non-small-cell lung cancer is used identify the subgroup of patients who are most likely to respond to EGFR antagonist chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-992B-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0563A626-9944-81B7-E050-BB89AD4370A5","beginDate":"2014-10-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA","dateModified":"2014-10-14","deletedIndicator":"No"},{"value":"ETV6-NTRK3 Fusion","valueDescription":"ETV6-NTRK3 Fusion Expression","ValueMeaning":{"publicId":"4621577","version":"1","preferredName":"ETV6-NTRK3 Fusion Expression","longName":"4621577","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ETV6-NTRK3 Fusion Protein Expression","conceptCode":"C37243","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4D16-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4D2F-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"EWSR-ATF1 Fusion","valueDescription":"EWSR1-ATF1 Fusion Expression","ValueMeaning":{"publicId":"4621579","version":"1","preferredName":"EWSR1-ATF1 Fusion Expression","longName":"4621579","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1-ATF1 Fusion Protein Expression","conceptCode":"C37232","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4D3C-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4D55-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"MECT1-MAML2","valueDescription":"MECT1-MAML2 Fusion Expression","ValueMeaning":{"publicId":"4621581","version":"1","preferredName":"MECT1-MAML2 Fusion Expression","longName":"4621581","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CRTC1-MAML2 Fusion Protein Expression","conceptCode":"C54218","definition":"No Value Exists","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4D62-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4D7B-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"ROS1 Translocation","valueDescription":"ROS1 Translocation","ValueMeaning":{"publicId":"4621582","version":"1","preferredName":"ROS1 Translocation","longName":"4621582","preferredDefinition":"Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.: This gene plays a role in receptor tyrosine phosphorylation signal transduction, and is thought to play a role in cellular growth or differentiation, but an exact function has not been substantiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromosomal Translocation Process","conceptCode":"C25756","definition":"Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"ROS1 Gene","conceptCode":"C18399","definition":"This gene plays a role in receptor tyrosine phosphorylation signal transduction, and is thought to play a role in cellular growth or differentiation, but an exact function has not been substantiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4D88-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4DA1-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"IDH1 Mutation","valueDescription":"IDH1 Gene Mutation","ValueMeaning":{"publicId":"4535022","version":"1","preferredName":"IDH1 Gene Mutation","longName":"4535022","preferredDefinition":"A change in the nucleotide sequence of the IDH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH1 Gene Mutation","conceptCode":"C118389","definition":"A change in the nucleotide sequence of the IDH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9854-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4DB5-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"IDH2 Mutation","valueDescription":"IDH2 Mutation","ValueMeaning":{"publicId":"4535023","version":"1","preferredName":"IDH2 Mutation","longName":"4535023","preferredDefinition":"A change in the nucleotide sequence of the IDH2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDH2 Gene Mutation","conceptCode":"C118390","definition":"A change in the nucleotide sequence of the IDH2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0563A626-9879-81B7-E050-BB89AD4370A5","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4DC9-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"PIK3CA Mutation","valueDescription":"PIK3CA Mutation","ValueMeaning":{"publicId":"4411273","version":"1","preferredName":"PIK3CA Mutation","longName":"4411273","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the PI3KCA (phosphatidyl inositol 3-kinase) gene on chromosome 3q26.32.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3CA Gene Mutation","conceptCode":"C96271","definition":"A change in the nucleotide sequence of the PIK3CA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF469A4B-6D3A-2C10-E040-BB89AD435709","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4DDD-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"MSI high","valueDescription":"Elevated Microsatellite Instability","ValueMeaning":{"publicId":"4621615","version":"1","preferredName":"Elevated Microsatellite Instability","longName":"4621615","preferredDefinition":"Raised or increased above normal levels or limits.: Genomic instability associated with defective DNA mismatch repair in tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Microsatellite Instability","conceptCode":"C36318","definition":"Genomic instability associated with the presence of hypermutability in specific genetic marker regions resulting from defective DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4E43-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4E5C-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"EBV Positive","valueDescription":"Epstein-Barr Virus Positive","ValueMeaning":{"publicId":"4621616","version":"1","preferredName":"Epstein-Barr Virus Positive","longName":"4621616","preferredDefinition":"An observation confirming something, such as the presence of a disease, condition, or microorganism.: A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B57384-4E69-2F30-E050-BB89AD435C53","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B57384-4E82-2F30-E050-BB89AD435C53","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"HRAS mutation","valueDescription":"HRAS Mutation","ValueMeaning":{"publicId":"4665052","version":"1","preferredName":"HRAS Mutation","longName":"4665052","preferredDefinition":"This gene plays a role in signal transduction and cellular communication.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HRAS Gene","conceptCode":"C17060","definition":"This gene plays a role in signal transduction and cellular communication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C8C9496-9B2B-A5D1-E050-BB89AD431A4E","latestVersionIndicator":"Yes","beginDate":"2015-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C8C9496-9B44-A5D1-E050-BB89AD431A4E","beginDate":"2015-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-01-13","modifiedBy":"ONEDATA","dateModified":"2015-01-13","deletedIndicator":"No"},{"value":"NRAS mutation","valueDescription":"NRAS Mutation","ValueMeaning":{"publicId":"4665053","version":"1","preferredName":"NRAS Mutation","longName":"4665053","preferredDefinition":"This gene plays a role in signal transduction and cell cycle regulation.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRAS Gene","conceptCode":"C25786","definition":"This gene plays a role in signal transduction and cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C8C9496-9B51-A5D1-E050-BB89AD431A4E","latestVersionIndicator":"Yes","beginDate":"2015-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C8C9496-9B6A-A5D1-E050-BB89AD431A4E","beginDate":"2015-01-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-01-13","modifiedBy":"ONEDATA","dateModified":"2015-01-13","deletedIndicator":"No"},{"value":"MECT1 Translocation","valueDescription":"MECT1 Translocation","ValueMeaning":{"publicId":"4621743","version":"1","preferredName":"MECT1 Translocation","longName":"4621743","preferredDefinition":"MECT1 Translocation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09B7A28A-92EF-3771-E050-BB89AD43163B","latestVersionIndicator":"Yes","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09B7A28A-9308-3771-E050-BB89AD43163B","beginDate":"2014-12-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-08","modifiedBy":"ONEDATA","dateModified":"2014-12-08","deletedIndicator":"No"},{"value":"Other RAS mutation","valueDescription":"Other RAS Mutation","ValueMeaning":{"publicId":"4826505","version":"1","preferredName":"Other RAS Mutation","longName":"4826505","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Critically involved in cell activation and replication in many cell types, and disruption of its regulation can lead to uncontrolled growth.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"RAS Family Oncogene","conceptCode":"C17061","definition":"A family of oncogenes that are highly homologous with the retrovirus-associated DNA sequences (ras) originally isolated from Harvey and Kirsten murine sarcoma viruses. Mutated or overexpressed forms of the human ras genes are associated with constitutive ras GTPase activity, increased cellular proliferation, and cell transformation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1613A185-6C4D-FB1D-E050-BB89AD436E25","latestVersionIndicator":"Yes","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1613A185-6C66-FB1D-E050-BB89AD436E25","beginDate":"2015-05-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-14","modifiedBy":"ONEDATA","dateModified":"2015-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4408771","version":"1","preferredName":"Prognostic Marker Name","preferredDefinition":"Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease.:The words or language units by which a thing is known.","longName":"C20069:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prognostic Marker","conceptCode":"C20069","definition":"Genes and proteins for which the expression or presence of can help predict the course and outcome of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EB51-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"ONEDATA","dateModified":"2014-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-EB62-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; Cleanup","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Molecular Prognostic Ma","type":"Preferred Question Text","description":"Tumor Molecular Prognostic Marker","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF466D8B-7DA9-C107-E040-BB89AD4314A4","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; 12/12/14 jc added Exceptional Responder CSI.  ---  Curated to support CTEP Exceptional Responder trial 7.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}